These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 25081300)

  • 1. Comparison of long-term impact of immunosuppressants at therapeutic doses on hepatic function and histological changes in unilateral nephrectomized rats.
    Chen Y; Lin H; Zhang Z; Lin Y; Lu Y; Yuan R; Li M; Nie P; Chen L; Qiu J; Chen L; Xu B; Lin W; Xu J; Du H; Liang J; Zhang Z
    Exp Toxicol Pathol; 2014 Dec; 66(9-10):423-8. PubMed ID: 25081300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
    Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
    Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term impact of immunosuppressants at therapeutic doses on male reproductive system in unilateral nephrectomized rats: a comparative study.
    Chen Y; Zhang Z; Lin Y; Lin H; Li M; Nie P; Chen L; Qiu J; Lu Y; Chen L; Xu B; Lin W; Zhang J; Du H; Liang J; Zhang Z
    Biomed Res Int; 2013; 2013():690382. PubMed ID: 23936832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of cyclosporine, tacrolimus and sirolimus on cellular senescence in renal epithelial cells.
    Koppelstaetter C; Kern G; Leierer G; Mair SM; Mayer G; Leierer J
    Toxicol In Vitro; 2018 Apr; 48():86-92. PubMed ID: 29309803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of gingival alterations in rats medicated with cyclosporine A, tacrolimus and sirolimus: a stereological study.
    Pamuk F; Cetinkaya BO; Ayas B; Keles GC; Gacar A
    J Periodontal Res; 2015 Oct; 50(5):629-36. PubMed ID: 25399832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diltiazem aggravates testicular function impairment induced by cyclosporine A or tacrolimus in unilateral nephrectomised rats.
    Lin Y; Zhang J; Lei W; Li M; Zhang Z; Lu Y; Chen L; Yang J; Liang J; Chen Y
    Andrologia; 2019 Jun; 51(5):e13251. PubMed ID: 30821033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus and sirolimus cause insulin resistance in normal sprague dawley rats.
    Larsen JL; Bennett RG; Burkman T; Ramirez AL; Yamamoto S; Gulizia J; Radio S; Hamel FG
    Transplantation; 2006 Aug; 82(4):466-70. PubMed ID: 16926589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of sirolimus plus tacrolimus versus sirolimus plus cyclosporine in high-risk renal allograft recipients: results from an open-label, randomized trial.
    Gaber AO; Kahan BD; Van Buren C; Schulman SL; Scarola J; Neylan JF;
    Transplantation; 2008 Nov; 86(9):1187-95. PubMed ID: 19005398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome.
    Perrakis A; Schwarz K; Yedibela S; Croner RS; Hohenberger W; Müller V
    Transplant Proc; 2011 Dec; 43(10):3702-7. PubMed ID: 22172830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin: a bone sparing immunosuppressant?
    Romero DF; Buchinsky FJ; Rucinski B; Cvetkovic M; Bryer HP; Liang XG; Ma YF; Jee WS; Epstein S
    J Bone Miner Res; 1995 May; 10(5):760-8. PubMed ID: 7543725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
    Cowan PA; Heizer KE
    Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
    Patsenker E; Schneider V; Ledermann M; Saegesser H; Dorn C; Hellerbrand C; Stickel F
    J Hepatol; 2011 Aug; 55(2):388-98. PubMed ID: 21168455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal function improves in liver transplant recipients when switched from a calcineurin inhibitor to sirolimus.
    Fairbanks KD; Eustace JA; Fine D; Thuluvath PJ
    Liver Transpl; 2003 Oct; 9(10):1079-85. PubMed ID: 14526403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestasis and regulation of genes related to drug metabolism and biliary transport in rat liver following treatment with cyclosporine A and sirolimus (Rapamycin).
    Bramow S; Ott P; Thomsen Nielsen F; Bangert K; Tygstrup N; Dalhoff K
    Pharmacol Toxicol; 2001 Sep; 89(3):133-9. PubMed ID: 11589784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: an analysis of the Scientific Registry of Transplant Recipients Database.
    Watt KD; Dierkhising R; Heimbach JK; Charlton MR
    Liver Transpl; 2012 Sep; 18(9):1029-36. PubMed ID: 22641474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
    Ganschow R; Albani J; Grabhorn E; Richter A; Burdelski M
    Pediatr Transplant; 2006 Mar; 10(2):220-4. PubMed ID: 16573611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
    Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
    Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus prevents short-term renal changes induced by ischemia-reperfusion injury in rats.
    Esposito C; Grosjean F; Torreggiani M; Esposito V; Mangione F; Villa L; Sileno G; Rosso R; Serpieri N; Molinaro M; Fasoli G; Dal Canton A
    Am J Nephrol; 2011; 33(3):239-49. PubMed ID: 21358177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.